NEUROSINA

NEUROSINA is dedicated to revolutionizing mental health care through cutting-edge neuroscience and cognitive science. Specializing in the development of advanced AI-based devices, NEUROSINA aims to significantly enhance the quality of life for patients dealing with neurological and mental disorders. The company's primary focus is on its innovative device, Epiphany, designed for individuals with drug-resistant epilepsy, offering continuous monitoring and early detection of seizure attacks.

NEUROSINA's Epiphany device employs advanced signal processing technology to monitor neural activity through non-invasive electrodes placed on the scalp. This data is then wirelessly transmitted to a smartphone, where sophisticated AI algorithms analyze the signals to predict potential seizure attacks. Located in Mashhad, IR, NEUROSINA is committed to improving diagnostic tools through a deep understanding of neural networks and artificial intelligence.

NEUROSINA is poised to make a substantial impact on the healthcare industry by providing accessible and effective solutions for managing neurological conditions. With a commitment to innovation and patient well-being, NEUROSINA is set to transform the landscape of mental health care. We invite the manager of NEUROSINA to create a customized and exclusive company showcase and product listing on our platform.